Publications by authors named "Mark Ensor"

Claim this Profile
N
Nicotine promotes AngII-induced abdominal aortic aortopathies in female and male mice: role of sex hormones.
Mark Ensor, Sean E Thatcher, Kristen McQuerry, Kory Heier, Heba M Ali

Clin Sci (Lond)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II-Induced Atherosclerosis, Abdominal Aortic Aneurysms, and Hypertension.
Yasir AlSiraj, Sean E Thatcher, Ching Ling Liang, Heba Ali, Mark Ensor

J Pharmacol Exp Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pseudomonas aeruginosa-derived pyocyanin reduces adipocyte differentiation, body weight, and fat mass as mechanisms contributing to septic cachexia.
Nika Larian, Mark Ensor, Sean E Thatcher, Victoria English, Andrew J Morris

Food Chem Toxicol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pilot Study of a Device and Drug Therapy for ADHD.
Markus Ville Tiitto, Rebecca Smith, Amy Banfield, Mark Ensor, Robert A Lodder

Webmedcentral· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of D-Tagatose in Glycemic Control in Subjects with Type 2 Diabetes.
Mark Ensor, Amy B Banfield, Rebecca R Smith, Jarrod Williams, Robert A Lodder

J Endocrinol Diabetes Obes· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Three Low-Doses of D-Tagatose on Glycemic Control Over Six Months in Subjects with Mild Type 2 Diabetes Mellitus Under Control with Diet and Exercise.
Mark Ensor, Jarrod Williams, Rebecca Smith, Amy Banfield, Robert A Lodder

J Endocrinol Diabetes Obes· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aequorin mutants with increased thermostability.
Xiaoge Qu, Laura Rowe, Emre Dikici, Mark Ensor, Sylvia Daunert

Anal Bioanal Chem· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioluminescence inhibition assay for the detection of hydroxylated polychlorinated biphenyls.
Krystal Teasley Hamorsky, C Mark Ensor, Emre Dikici, Patrizia Pasini, Leonidas Bachas

Anal Chem· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioluminescence and its impact on bioanalysis.
Daniel Scott, Emre Dikici, Mark Ensor, Sylvia Daunert

Annu Rev Anal Chem (Palo Alto Calif)· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclic AMP receptor protein-aequorin molecular switch for cyclic AMP.
Daniel Scott, Krystal Teasley Hamorsky, C Mark Ensor, Kimberly W Anderson, Sylvia Daunert

Bioconjug Chem· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paper strip whole cell biosensors: a portable test for the semiquantitative detection of bacterial quorum signaling molecules.
Anjali Struss, Patrizia Pasini, C Mark Ensor, Nilesh Raut, Sylvia Daunert

Anal Chem· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulating the bioluminescence emission of photoproteins by in vivo site-directed incorporation of non-natural amino acids.
Laura Rowe, Mark Ensor, Ryan Mehl, Sylvia Daunert

ACS Chem Biol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human cardiac troponin I: a Langmuir monolayer study.
Jhony Orbulescu, Miodrag Micic, Mark Ensor, Sanja Trajkovic, Sylvia Daunert

Langmuir· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A bioluminescent molecular switch for glucose.
Krystal Teasley Hamorsky, C Mark Ensor, Yinan Wei, Sylvia Daunert

Angew Chem Int Ed Engl· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infrared reflection-absorption spectroscopy and polarization-modulated infrared reflection-absorption spectroscopy studies of the aequorin langmuir monolayer.
Chengshan Wang, Miodrag Micic, Mark Ensor, Sylvia Daunert, Roger M Leblanc

J Phys Chem B· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aequorin-based homogeneous cortisol immunoassay for analysis of saliva samples.
Laura Rowe, Sapna Deo, Josh Shofner, Mark Ensor, Sylvia Daunert

Bioconjug Chem· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioluminescence immunoassay for angiotensin II using aequorin as a label.
Xiaoge Qu, Sapna K Deo, Emre Dikici, Mark Ensor, Michael Poon

Anal Biochem· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surface properties of "jellyfish": Langmuir monolayer and Langmuir-Blodgett film studies of recombinant aequorin.
Chengshan Wang, Miodrag Micic, Mark Ensor, Sylvia Daunert, Roger M Leblanc

Langmuir· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegylated arginine deiminase lowers hepatitis C viral titers and inhibits nitric oxide synthesis.
Francesco Izzo, Maurizio Montella, Antonio Pio Orlando, Guglielmo Nasti, Gerardo Beneduce, C Mark Ensor

J Gastroenterol Hepatol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies.
Paolo A Ascierto, Stefania Scala, Giuseppe Castello, Antonio Daponte, Ester Simeone, C Mark Ensor

J Clin Oncol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies.
Francesco Izzo, Paolo Marra, Gerardo Beneduce, Giuseppe Castello, Paolo Vallone, C Mark Ensor

J Clin Oncol· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regression of hepatocellular cancer in a patient treated with arginine deiminase.
Steven A Curley, John S Bomalaski, C Mark Ensor, Frederick W Holtsberg, Mike A Clark

Hepatogastroenterology· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: a method for identifying cancers sensitive to arginine deprivation.
Brian J Dillon, Victor G Prieto, Steven A Curley, C Mark Ensor, Frederick W Holtsberg

Cancer· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uricase formulated with polyethylene glycol (uricase-PEG 20): biochemical rationale and preclinical studies.
John S Bomalaski, Frederick W Holtsberg, C Mark Ensor, Mike A Clark

J Rheumatol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biochemical characterization of the arginine degrading enzymes arginase and arginine deiminase and their effect on nitric oxide production.
Brian J Dillon, Frederick W Holtsberg, C Mark Ensor, John S Bomalaski, Mike A Clark

Med Sci Monit· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis